BCLI Financials 07/15/2014 20:05:30
BrainStorm Cell Therapeutics Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 2,917 1,770 1,689 1,045
Sales, General and Admin. 2,101 1,748 2,205 1,544
Non-Recurring Items - - - -
Other - - - -
Operating Income (5,018) (3,518) (3,894) (2,589)
Income From Continuing Operations
Add'l Income/Expense Items - - 132 -
Earnings Before Interest and Tax (4,874) (3,425) (3,913) (2,400)
Interest Expense - - - -
Earnings Before Tax (4,874) (3,425) (3,913) (2,400)
Income Tax 25 5 5 19
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,899) (3,430) (3,918) (2,419)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,899) (3,430) (3,918) (2,419)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,899) (3,430) (3,918) (2,419)